Peripheral Artery Disease Market Recent Development, Growth And Size, Share Analysis By 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Peripheral Artery Disease Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $5.67 billion In 2028 At A CAGR Of 7.3%.

The peripheral artery disease market size has grown strongly in recent years. It will grow from $3.97 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives..

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, targeted drug therapies.. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), shift to outpatient settings..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Peripheral Artery Disease Market Major Segments
The peripheral artery disease market covered in this report is segmented -

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users

Key Driver - Rising Prevalence Of Peripheral Artery Diseases Expected To Drive Growth In Peripheral Artery Disease Market

The rise in the prevalence of peripheral artery diseases is expected to propel the growth of the peripheral artery disease market going forward. Peripheral artery disease refers to the narrowing or blockage of arteries outside the heart, usually in the legs, resulting in reduced blood flow and potential complications. Peripheral artery disease treatment helps reduce peripheral artery disease symptoms, enhance mobility, and decrease the risk of severe complications that improve patients' well-being. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery disease increased from 11.3 million in 1995 to 21 million in 2020 and estimated to reach 23.8 million by 2030. Therefore, the rise in the prevalence of peripheral artery diseases is driving the growth of the peripheral artery disease market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12068&type=smp

Prominent Trend - Technologically Advanced Solution For Peripheral Artery Disease Treatment

Technological advancements are a key trend gaining popularity in the peripheral artery disease market. Major companies operating in the peripheral artery disease market are adopting technologically advanced surgery treatments to sustain their position in the market. For instance, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, introduced chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter for the treatment of patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon is the first and only balloon catheter in the device that combines therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It uses pillow-like structures covered with a therapeutic chemical to open in tiny parts to offer an alternate therapy to standard drug-coated balloon angioplasty for individuals suffering from peripheral artery disease. As a result, the balloon surface increases, allowing for more effective medication delivery to the vessel wall and eliminating the requirement for permanent implants.

Peripheral Artery Disease Market Players
Major companies operating in the peripheral artery disease market report are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, Natus Medical Inc., AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Lombard Medical Inc., Avinger Inc., Ra Medical Systems Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the peripheral artery disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Peripheral Artery Disease Market Report Structure
3. Peripheral Artery Disease Market Trends And Strategies
4. Peripheral Artery Disease Market - Macro Economic Scenario
5. Peripheral Artery Disease Market Size And Growth
…..
27. Peripheral Artery Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.